Jennifer P Ker, MD | |
222 22nd Ave N, Nashville, TN 37203-1852 | |
(629) 255-2238 | |
(629) 255-4183 |
Full Name | Jennifer P Ker |
---|---|
Gender | Female |
Speciality | Allergy/immunology |
Experience | 20 Years |
Location | 222 22nd Ave N, Nashville, Tennessee |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1639226590 | NPI | - | NPPES |
103I031452 | Other | TN | MEDICARE PTAN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | MD0000042707 (Tennessee) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Heritage Medical Associates Pc | 4688651037 | 158 |
News Archive
Zogenix, Inc., a privately held pharmaceutical company, announced today that it has closed a $35 million second tranche of a Series B preferred stock financing. The Series B round was increased from $51 million, previously announced in September, to $71 million. The additional $20 million investment was made by Chicago Growth Partners, which will now be represented on the Zogenix Board of Directors by Dr. Arda Minocherhomjee.
A Kansas scientist has developed a device to stabilize fractures during battle in the hopes of cutting down the number of amputations needed. Meanwhile, St. Jude researchers have launched a study of a new heart defibrillator.
To more effectively and efficiently meet the needs of at-risk families, a Georgia State University study suggests the introduction of a technological enhancement to improve acquisition of skills developed during parent-infant sessions.
When asked to choose a health care provider based only on cost, consumers choose the more expensive option, according to a new study funded by HHS' Agency for Healthcare Research and Quality (AHRQ) that appears in the March issue of Health Affairs.
Naturally elevated levels of the antioxidant urate may slow the progression of Parkinson's disease in men. Researchers from the MassGeneral Institute for Neurodegenerative Disease (MGH-MIND) and Harvard School of Public Health (HSPH) examined data from an earlier study and found that, among recently diagnosed Parkinson's patients, those with the highest urate levels had a significantly slower rate of disease progression during the two-year study period.
› Verified 9 days ago
Entity Name | Heritage Medical Associates Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548284060 PECOS PAC ID: 4688651037 Enrollment ID: O20040702000463 |
News Archive
Zogenix, Inc., a privately held pharmaceutical company, announced today that it has closed a $35 million second tranche of a Series B preferred stock financing. The Series B round was increased from $51 million, previously announced in September, to $71 million. The additional $20 million investment was made by Chicago Growth Partners, which will now be represented on the Zogenix Board of Directors by Dr. Arda Minocherhomjee.
A Kansas scientist has developed a device to stabilize fractures during battle in the hopes of cutting down the number of amputations needed. Meanwhile, St. Jude researchers have launched a study of a new heart defibrillator.
To more effectively and efficiently meet the needs of at-risk families, a Georgia State University study suggests the introduction of a technological enhancement to improve acquisition of skills developed during parent-infant sessions.
When asked to choose a health care provider based only on cost, consumers choose the more expensive option, according to a new study funded by HHS' Agency for Healthcare Research and Quality (AHRQ) that appears in the March issue of Health Affairs.
Naturally elevated levels of the antioxidant urate may slow the progression of Parkinson's disease in men. Researchers from the MassGeneral Institute for Neurodegenerative Disease (MGH-MIND) and Harvard School of Public Health (HSPH) examined data from an earlier study and found that, among recently diagnosed Parkinson's patients, those with the highest urate levels had a significantly slower rate of disease progression during the two-year study period.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Jennifer P Ker, MD 222 22nd Ave N, Nashville, TN 37203-1852 Ph: (629) 255-3486 | Jennifer P Ker, MD 222 22nd Ave N, Nashville, TN 37203-1852 Ph: (629) 255-2238 |
News Archive
Zogenix, Inc., a privately held pharmaceutical company, announced today that it has closed a $35 million second tranche of a Series B preferred stock financing. The Series B round was increased from $51 million, previously announced in September, to $71 million. The additional $20 million investment was made by Chicago Growth Partners, which will now be represented on the Zogenix Board of Directors by Dr. Arda Minocherhomjee.
A Kansas scientist has developed a device to stabilize fractures during battle in the hopes of cutting down the number of amputations needed. Meanwhile, St. Jude researchers have launched a study of a new heart defibrillator.
To more effectively and efficiently meet the needs of at-risk families, a Georgia State University study suggests the introduction of a technological enhancement to improve acquisition of skills developed during parent-infant sessions.
When asked to choose a health care provider based only on cost, consumers choose the more expensive option, according to a new study funded by HHS' Agency for Healthcare Research and Quality (AHRQ) that appears in the March issue of Health Affairs.
Naturally elevated levels of the antioxidant urate may slow the progression of Parkinson's disease in men. Researchers from the MassGeneral Institute for Neurodegenerative Disease (MGH-MIND) and Harvard School of Public Health (HSPH) examined data from an earlier study and found that, among recently diagnosed Parkinson's patients, those with the highest urate levels had a significantly slower rate of disease progression during the two-year study period.
› Verified 9 days ago
Dr. Michael M Dao, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 1161 Murfreesboro Pike Ste 500, Nashville, TN 37217 Phone: 615-415-5875 Fax: 615-777-3297 | |
Keegan M Smith, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 222 22nd Ave N, Nashville, TN 37203 Phone: 629-255-2145 Fax: 629-255-4030 | |
Lisa Lancaster, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3601 Tvc, Nashville, TN 37232 Phone: 615-322-3000 | |
Dan S Sanders Iii, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 300 20th Ave N, Suite 100, Nashville, TN 37203 Phone: 615-340-4731 Fax: 615-340-4729 | |
William Bennett Ralph Jr., MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 330 22nd Ave N, Nashville, TN 37203 Phone: 615-329-9431 Fax: 615-329-9435 | |
Lori Russell, FNP-BC Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
David Hagaman, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3601 Tvc, Nashville, TN 37232 Phone: 615-322-3000 |